Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Volastra Therapeutics
company
About
Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers.
- 51 - 100
Highlights
Details
- Last Funding Type
- Seed
- Last Funding Money Raised
- $12M
- Industries
- Biotechnology,Medical
- Founded date
- Jan 1, 2019
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers by exploiting unique insights into chromosomal instability
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$44M
Volastra Therapeutics has raised a total of
$44M
in funding over 2 rounds. Their latest funding was raised on
Apr 6, 2021 from a Seed round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 6, 2021 | Seed | $32M | 1 | — | — | Detail |
| Feb 11, 2020 | Seed | $12M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Volastra Therapeutics is funded by 2 investors.
ARCH Venture Partners
and Global health sciences venture fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
ARCH Venture Partners
|
— | Seed |
|
|
— | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
